Filter Results:
(316)
Show Results For
- All HBS Web (499)
- Faculty Publications (182)
Show Results For
- All HBS Web (499)
- Faculty Publications (182)
Sort by
- October 2020
- Teaching Plan
Merck: COVID-19 Vaccines
By: Willy C. Shih
COVID-19 infections were still climbing across the U.S. and many other parts of the world in September 2020, and it seemed that every time Ken Frazier, the CEO of Merck & Co. consented to an interview in recent months he always seemed to hear the same question,... View Details
- 12 Mar 2014
- Research & Ideas
Entrepreneurship and Multinationals Drive Globalization
volumes, and in the spirit of the whole being greater than the sum of the parts, I sought to pull together my research and conclusions in this book, in the hope of reaching broader audiences. I address three key themes. First, I show that... View Details
- November 2023 (Revised April 2024)
- Case
BiomX: Bringing Phage Back to the Stage
By: Paul A. Gompers, Elie Ofek, Orna Dan and Emilie Billaud
In the spring of 2023, and following the favorable results of a trial involving its phage cocktail for treating lung infections among cystic fibrosis (CF) patients, the leadership of BiomX had several critical issues to wrestle with. First, given its precarious... View Details
Keywords: Working Capital; Financing and Loans; Health Testing and Trials; Product Development; Research and Development; Science-Based Business; Commercialization; Pharmaceutical Industry; Pharmaceutical Industry
Gompers, Paul A., Elie Ofek, Orna Dan, and Emilie Billaud. "BiomX: Bringing Phage Back to the Stage." Harvard Business School Case 524-051, November 2023. (Revised April 2024.)
- 21 Nov 2006
- First Look
First Look: November 21, 2006
Kathryn S. Roloff Abstract The emergence of a research literature on team learning has been driven by at least two factors. First, longstanding interest in what makes organizational work teams effective leads naturally to questions of how... View Details
Keywords: Sean Silverthorne
- 26 Jan 2009
- Research & Ideas
Where is Home for the Global Firm?
example, the fragmentation of production around the world, distribution outlets worldwide, and research and development facilities that capitalize on local talent pools. But we still basically think that firms belong to some home country... View Details
Keywords: by Martha Lagace
- January 1994
- Case
Evolving Finance Function: Judy C. Lewent at Merck & Co., Inc.
By: Timothy A. Luehrman
This case examines the career path of Merck's CFO, Judy C. Lewent, as a way of tracing changes over time in Merck's finance function. It describes the adoption of innovative quantitative analytical models, changes in job definitions and in the organization of the... View Details
Keywords: Finance; Mathematical Methods; Personal Development and Career; Organizational Design; Innovation and Invention; Pharmaceutical Industry
Luehrman, Timothy A. "Evolving Finance Function: Judy C. Lewent at Merck & Co., Inc." Harvard Business School Case 294-014, January 1994.
- 28 Feb 2019
- Cold Call Podcast
Pursuing Precision Medicine at Intermountain Healthcare
- 28 Aug 2017
- Research & Ideas
Should Industry Competitors Cooperate More to Solve World Problems?
are persistent issues that in many cases have worsened. "Addressing these issues is critical for the future competitiveness of these industries" In our competitive landscape, ESG efforts are guided by economic incentives. Indeed, my View Details
- 30 Jun 2003
- Research & Ideas
Computer Security is For Managers, Too
each warrants. A bank, for instance, might assign the greatest amount of protection to the database that stores its customers' financial information. For a pharmaceutical company, it might be the research... View Details
- 12 Oct 2006
- First Look
First Look: October 12, 2006
responsible" investments as well as some consumers, activists, and potential employees. Unfortunately, there is little evidence about the validity of these ratings. We examine how well two of the most widely used ratings—those of Kinder, Lydenberg, Domini View Details
Keywords: Sean Silverthorne
- 09 Jan 2007
- First Look
First Look: January 9, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707413 Teva Pharmaceutical Industries, Ltd. Harvard Business School Case 707-441 Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=707441 ... View Details
Keywords: Martha Lagace
- 21 Apr 2014
- Research & Ideas
Bio-Piracy: When Western Firms Usurp Eastern Medicine
In May 1995, two scientists at the University of Mississippi were granted an American patent for the use of turmeric to treat flesh wounds. Soon thereafter, an Indian research organization won a lawsuit challenging the novelty of the... View Details
- 13 Feb 2006
- Research & Ideas
The Hidden Market for Babies
process of thinking about possibly adopting a third child (we already had two through old-fashioned means). And as I was doing personal research into adoption, it struck me one day that adoption was really just the flip side of... View Details
- 22 Apr 2008
- First Look
First Look: April 22, 2008
Business Harvard Business School Case 608-136 Novartis is a science-based drug company, which has important implications for its business strategy. It is one of the largest pharmaceutical companies in the world with over $38B in sales in... View Details
Keywords: Martha Lagace
- 07 Aug 2009
- What Do You Think?
Why Can’t Americans Get Health Care Right?
above are numerous in a channel that includes, in your comments, food and tobacco producers of unhealthy products (Christy Hitchens, Tom Dolembo); lifestyle equipment and service providers; developers and manufacturers of high-cost View Details
- 26 Sep 2006
- First Look
First Look: September 26, 2006
negative relation between this measure and both future stock returns and future profitability. The economic and statistical significance of our results is stronger than in previous research focusing on individual categories of corporate... View Details
Keywords: Sean Silverthorne
- 24 Jul 2014
- Op-Ed
Reform Tax Law to Keep US Firms at Home
I am a Professor of Finance at Harvard Business School, a Professor of Law at Harvard Law School, and a Research Associate of the National Bureau of Economic Research. Recent merger transactions highlight long-simmering problems in the US... View Details
- 06 May 2008
- First Look
First Look: May 6, 2008
company which had been put up for sale by pharmaceutical giant Pfizer. Examining the decision from a strategic perspective, the (A) case provides brief histories of the two companies; traces the global confectionery industry, focusing... View Details
Keywords: Martha Lagace
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
asking, is this the right business model? But there are no answers. The market and technology are constantly changing," Riesenfeld remarks. Important Sounding Board The biotech industry presents similar challenges in a space littered with failed companies. When... View Details
- 01 May 2007
- First Look
First Look: May 1, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=207113 Strategy in the 21st Century Pharmaceutical Industry: Merck & Co. and Pfizer Inc. Harvard Business School Case 707-509 The global View Details
Keywords: Sean Silverthorne